PH12215A - B-adreneroic receptor blocking agents - Google Patents

B-adreneroic receptor blocking agents

Info

Publication number
PH12215A
PH12215A PH18264A PH18264A PH12215A PH 12215 A PH12215 A PH 12215A PH 18264 A PH18264 A PH 18264A PH 18264 A PH18264 A PH 18264A PH 12215 A PH12215 A PH 12215A
Authority
PH
Philippines
Prior art keywords
adreneroic
blocking agents
receptor blocking
receptor
agents
Prior art date
Application number
PH18264A
Other languages
English (en)
Inventor
R Prasad
K Tirtje
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PH12215A publication Critical patent/PH12215A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
PH18264A 1975-04-09 1976-03-26 B-adreneroic receptor blocking agents PH12215A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/566,600 US4081447A (en) 1975-04-09 1975-04-09 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof

Publications (1)

Publication Number Publication Date
PH12215A true PH12215A (en) 1978-11-29

Family

ID=24263564

Family Applications (1)

Application Number Title Priority Date Filing Date
PH18264A PH12215A (en) 1975-04-09 1976-03-26 B-adreneroic receptor blocking agents

Country Status (14)

Country Link
US (1) US4081447A (zh)
JP (1) JPS5919539B2 (zh)
CA (1) CA1066282A (zh)
CH (1) CH597193A5 (zh)
DE (1) DE2615406A1 (zh)
DK (1) DK156776A (zh)
FR (1) FR2306696A1 (zh)
GB (1) GB1496995A (zh)
MX (1) MX3217E (zh)
NL (1) NL7603586A (zh)
NO (1) NO146432C (zh)
PH (1) PH12215A (zh)
SE (1) SE428470B (zh)
ZA (1) ZA761727B (zh)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
CH619453A5 (zh) * 1976-03-17 1980-09-30 Otsuka Pharma Co Ltd
DE2719562C2 (de) * 1976-05-08 1986-05-07 Otsuka Pharmaceutical Co. Ltd., Tokio/Tokyo 3, 4-Dihydrocarbostyrilderivate, Verfahren zu deren Herstellung und Arzneimittel, welche diese enthalten
DE2644833A1 (de) * 1976-10-05 1978-04-20 Boehringer Sohn Ingelheim Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung
DE2702600A1 (de) * 1977-01-22 1978-07-27 Thomae Gmbh Dr K Neue aminoalkoxyphenyl-derivate
NZ187066A (en) * 1977-05-03 1981-02-11 Hoffmann La Roche 4-(3-substitutedamino-2-hydroxypropoxy)-benzimidazolidin-2-(ones or thiones)
US4314943A (en) * 1977-07-13 1982-02-09 Mead Johnson & Company Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
CA1108619A (en) * 1977-08-12 1981-09-08 Carl H. Ross 4-hydroxy-2-benzimidazolinone derivatives and the preparation thereof
AU518814B2 (en) * 1979-01-30 1981-10-22 Otsuka Pharamaceutical Co. Glaucoma treatment
US4495352A (en) * 1979-02-13 1985-01-22 Mead Johnson & Company Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
DD150456A5 (de) * 1979-03-01 1981-09-02 Ciba Geigy Ag Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
JPS56122356A (en) * 1980-02-29 1981-09-25 Otsuka Pharmaceut Co Ltd Carbostyril derivative
US4656168A (en) * 1980-12-23 1987-04-07 Merck & Co., Inc. (3-aralkylamino-2-or-propoxy)heterocyclic compounds in method of effecting bronchodilation
US4331679A (en) * 1980-12-23 1982-05-25 Merck Sharp & Dohme (I.A.) Corp. (3-Aralkylamino-2-or-propoxy) heterocyclic compounds
US4442094A (en) * 1980-12-23 1984-04-10 Merck & Co., Inc. (3-Aralkylamino-2-or-propoxy)heterocyclic compounds
US4349673A (en) * 1980-12-23 1982-09-14 Merck & Co., Inc. Benzoxazines
AU532361B2 (en) * 1981-09-01 1983-09-29 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
CH655110A5 (de) * 1982-09-03 1986-03-27 Otsuka Pharma Co Ltd Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten.
DE3544172A1 (de) * 1985-12-13 1987-06-19 Lentia Gmbh Neue kristalline salze von aryloxy-propanolaminen, verfahren zu ihrer herstellung und ihre verwendung
JPH07285940A (ja) * 1988-08-10 1995-10-31 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
JP2711437B2 (ja) * 1988-08-10 1998-02-10 大塚製薬 株式会社 カルボスチリル誘導体
WO1994003425A2 (en) * 1992-07-31 1994-02-17 Syntex (U.S.A.) Inc. Carbostyril derivatives for the treatment of arrhythmia
DK0660715T3 (da) * 1992-09-18 1998-01-19 Otsuka Pharma Co Ltd Carbostyrilderivater som antiarytmiske midler

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1058822A (en) * 1963-07-30 1967-02-15 Ici Ltd 3-amino-2-hydroxypropoxy heterocyclic derivatives
BE790165A (fr) * 1971-12-14 1973-02-15 Parke Davis & Co Nouveaux aminoalcanols et procede pour les preparer
US3910924A (en) * 1972-04-13 1975-10-07 Otsuka Pharma Co Ltd 3,4-Dihydrocarbostyril derivatives and a process for preparing the same
JPS48103590A (zh) * 1972-04-13 1973-12-25

Also Published As

Publication number Publication date
SE428470B (sv) 1983-07-04
FR2306696A1 (fr) 1976-11-05
US4081447A (en) 1978-03-28
CH597193A5 (zh) 1978-03-31
GB1496995A (en) 1978-01-05
ZA761727B (en) 1977-03-30
AU1226076A (en) 1977-09-29
FR2306696B1 (zh) 1979-09-21
NO761216L (zh) 1976-10-12
JPS5919539B2 (ja) 1984-05-07
NL7603586A (nl) 1976-10-12
CA1066282A (en) 1979-11-13
JPS51122077A (en) 1976-10-25
NO146432C (no) 1982-09-29
DK156776A (da) 1976-10-10
DE2615406A1 (de) 1976-10-14
NO146432B (no) 1982-06-21
SE7604171L (sv) 1976-10-10
MX3217E (es) 1980-07-22

Similar Documents

Publication Publication Date Title
ZA762966B (en) Chemitherapeutic agents
JPS5239903A (en) Construction device
PH12215A (en) B-adreneroic receptor blocking agents
AU1494176A (en) Securing device
JPS51122091A (en) Antiibacterial agent
JPS5237316A (en) Fixing device
JPS5215139A (en) Fixing device
JPS5214798A (en) Antiibacterial agent
JPS5252762A (en) Blocking element
MY8100290A (en) Gielling agents
JPS525787A (en) Antiibacterial agent
JPS51150112A (en) Attachment device
JPS51112527A (en) Antiivirus agent
JPS5261231A (en) Antiitumor agent
GB1541325A (en) Locking device
JPS5268195A (en) Antiibacterial agent
ZA766967B (en) Smell-removing agent
GB1550921A (en) Locking device
JPS5263186A (en) Clouddproofing agents
JPS527420A (en) Antimelancholia agent
JPS5275677A (en) Releasing agent
GB1539288A (en) Heat-sensitising agents
GB1543568A (en) Seat construction
JPS51112447A (en) Antiiscale agent
JPS5265290A (en) Antiibacterial agent